According to court documents, Martin Shkreli, the notorious “Pharma bro,” is also a deadbeat. Financial services firm Marks Paneth claims that he owes them nearly $1.7 million, as stated in a filing with the Manhattan Supreme Court.
Shkreli, the former pharmaceutical executive who was sentenced to seven years in prison in 2017 for securities fraud and banned from the industry, rose to infamy in 2015. He made headlines when his company Turing Pharmaceuticals acquired the rights to the life-saving cancer and AIDS drug Daraprim, and dramatically increased its price from $13.50 per pill to $750.
Follow Google NewsDenial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
